How to appeal a Horizon Blue Cross Blue Shield of New Jersey cardiac devices & procedures denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Horizon Blue Cross Blue Shield of New Jersey-specific note: Only BCBS licensee in New Jersey; ~3.7M members. OMNIA Health Plans (tiered network) generate frequent appeals — tier-2 hospital usage carries higher cost share. NJ DOBI oversight; NJ has a strong external review program (IHCAP via Maximus).

What Horizon Blue Cross Blue Shield of New Jersey's policy requires for cardiac devices & procedures

Cited policy: BCBS — Transcatheter Mitral Valve Repair / Anthem clinical guideline TEER

COAPT phenotype: EF 20-50%, severe secondary MR, NYHA II-IVa on GDMT >=3 months, prohibitive surgical risk. Heart Team evaluation per NCD 20.34.

How Horizon Blue Cross Blue Shield of New Jersey denies cardiac devices & procedures — and how to counter it

Where Horizon Blue Cross Blue Shield of New Jersey pushes back: 1) Functional MR investigational; 2) EF outside COAPT window (20-50%); 3) GDMT not optimized; 4) Surgical candidate determination unclear.

Counter-arguments that hold up: Demonstrate COAPT phenotype: EF, EROA, regurgitant volume, NYHA, GDMT trial. Cite COAPT NEJM 2018 + NCD 20.34 + 2020/2023 VHD Guideline Class IIa for secondary MR. Heart Team consensus with surgical risk attestation; STS-PROM >=8% or prohibitive risk.

What Horizon Blue Cross Blue Shield of New Jersey typically denies for cardiac devices & procedures

Across Horizon Blue Cross Blue Shield of New Jersey's commercial and Medicare books, denials cluster around a small number of patterns. For cardiac devices & procedures, expect:

• OMNIA tier-1 vs tier-2 provider disputes
• Step therapy on biologics
• Behavioral health prior auth
• Out-of-state emergency reductions

Treatments most often denied in this category

These are the cardiac devices & procedures treatments most often flagged for prior auth, step therapy, or medical necessity review:

• ICD (primary)
• ICD (secondary)
• CRT-D / CRT-P
• Watchman LAAC
• TAVR (high risk)
• TAVR (intermediate)

How to submit the appeal to Horizon Blue Cross Blue Shield of New Jersey

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Horizon Blue Cross Blue Shield of New Jersey cited in the denial.
3. File the appeal through Horizon Blue Cross Blue Shield of New Jersey's portal (members: https://www.horizonblue.com ; providers: https://www.horizonblue.com/providers). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In NJ, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Horizon Blue Cross Blue Shield of New Jersey's prior-authorization criteria by drug: Horizon Blue Cross Blue Shield of New Jersey PA criteria on ApprovalHelp.